ID   DCLK1_HUMAN             Reviewed;         740 AA.
AC   O15075; B7Z3E9; Q5VZY8; Q5VZZ0; Q5VZZ1;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2000, sequence version 2.
DT   12-APR-2017, entry version 170.
DE   RecName: Full=Serine/threonine-protein kinase DCLK1;
DE            EC=2.7.11.1;
DE   AltName: Full=Doublecortin domain-containing protein 3A;
DE   AltName: Full=Doublecortin-like and CAM kinase-like 1;
DE   AltName: Full=Doublecortin-like kinase 1;
GN   Name=DCLK1; Synonyms=DCAMKL1, DCDC3A, KIAA0369;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3 AND 4).
RX   PubMed=9747029; DOI=10.1007/s100380050063;
RA   Omori Y., Suzuki M., Ozaki K., Harada Y., Nakamura Y., Takahashi E.,
RA   Fujiwara T.;
RT   "Expression and chromosomal localization of KIAA0369, a putative
RT   kinase structurally related to Doublecortin.";
RL   J. Hum. Genet. 43:169-177(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Fetal brain;
RX   PubMed=10036192; DOI=10.1006/geno.1998.5718;
RA   Sossey-Alaoui K., Srivastava A.K.;
RT   "DCAMKL1, a brain-specific transmembrane protein on 13q12.3 that is
RT   similar to doublecortin (DCX).";
RL   Genomics 56:121-126(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9205841; DOI=10.1093/dnares/4.2.141;
RA   Nagase T., Ishikawa K., Nakajima D., Ohira M., Seki N., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. VII.
RT   The complete sequences of 100 new cDNA clones from brain which can
RT   code for large proteins in vitro.";
RL   DNA Res. 4:141-150(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E.,
RA   Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T.,
RA   Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R.,
RA   Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S.,
RA   Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M.,
RA   Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J.,
RA   Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E.,
RA   Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L.,
RA   Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J.,
RA   Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S.,
RA   Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J.,
RA   Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M.,
RA   King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A.,
RA   Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S.,
RA   Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S.,
RA   Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A.,
RA   Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L.,
RA   Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.M.,
RA   Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (FEB-2008) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   TISSUE SPECIFICITY.
RX   PubMed=10051403; DOI=10.1006/geno.1998.5673;
RA   Matsumoto N., Pilz D.T., Ledbetter D.H.;
RT   "Genomic structure, chromosomal mapping, and expression pattern of
RT   human DCAMKL1 (KIAA0369), a homologue of DCX (XLIS).";
RL   Genomics 56:179-183(1999).
RN   [9]
RP   INDUCTION, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16548883; DOI=10.1111/j.1462-5822.2005.00644.x;
RA   Leong W.F., Chow V.T.;
RT   "Transcriptomic and proteomic analyses of rhabdomyosarcoma cells
RT   reveal differential cellular gene expression in response to
RT   enterovirus 71 infection.";
RL   Cell. Microbiol. 8:565-580(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-352, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [11]
RP   STRUCTURE BY NMR OF 51-156.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the N-terminal DCX domain of human
RT   doublecortin-like kinase.";
RL   Submitted (NOV-2003) to the PDB data bank.
RN   [12]
RP   VARIANTS [LARGE SCALE ANALYSIS] CYS-29; MET-46; GLN-93; PHE-291 AND
RP   HIS-292.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Probable kinase that may be involved in a calcium-
CC       signaling pathway controlling neuronal migration in the developing
CC       brain. May also participate in functions of the mature nervous
CC       system.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC         Comment=Additional isoforms seem to exist. Type A (AS and AL)
CC         and type B (BS and BL) isoforms differ respectively by the
CC         presence or absence of the doublecortin domain. An alternative
CC         splicing occurring in 3' of the mRNA produces the long (L)
CC         instead of the short (S) isoforms.;
CC       Name=2; Synonyms=AL;
CC         IsoId=O15075-1; Sequence=Displayed;
CC       Name=1; Synonyms=AS;
CC         IsoId=O15075-2; Sequence=VSP_004907;
CC       Name=3; Synonyms=BS;
CC         IsoId=O15075-3; Sequence=VSP_004905, VSP_004906, VSP_004907;
CC       Name=4; Synonyms=BL;
CC         IsoId=O15075-4; Sequence=VSP_004905, VSP_004906;
CC   -!- TISSUE SPECIFICITY: In fetal tissues, highly expressed in brain,
CC       detectable in lung and liver, but not in kidney. In adult tissues,
CC       expressed ubiquitously in the brain, detectable in the heart,
CC       liver, spleen, thymus, prostate, testis, ovary, small intestine
CC       and colon. The type A isoforms seem to be expressed predominantly
CC       in fetal brain whereas type B isoforms are expressed abundantly in
CC       both fetal and adult brain. {ECO:0000269|PubMed:10051403}.
CC   -!- INDUCTION: Up-regulated in response to enterovirus 71 (EV71)
CC       infection (at protein level). {ECO:0000269|PubMed:16548883}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK
CC       Ser/Thr protein kinase family. CaMK subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA20824.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB002367; BAA20824.2; ALT_INIT; mRNA.
DR   EMBL; AL157760; CAH70167.1; -; Genomic_DNA.
DR   EMBL; AL157694; CAH70167.1; JOINED; Genomic_DNA.
DR   EMBL; AL160392; CAH70167.1; JOINED; Genomic_DNA.
DR   EMBL; AL390029; CAH70167.1; JOINED; Genomic_DNA.
DR   EMBL; AL157760; CAH70170.1; -; Genomic_DNA.
DR   EMBL; AK295777; BAH12185.1; -; mRNA.
DR   EMBL; AL157760; CAH70168.1; -; Genomic_DNA.
DR   EMBL; AL157694; CAH70168.1; JOINED; Genomic_DNA.
DR   EMBL; AL160392; CAH70168.1; JOINED; Genomic_DNA.
DR   EMBL; AL390029; CAH70168.1; JOINED; Genomic_DNA.
DR   EMBL; AL160392; CAH70261.1; -; Genomic_DNA.
DR   EMBL; AL157694; CAH70261.1; JOINED; Genomic_DNA.
DR   EMBL; AL157760; CAH70261.1; JOINED; Genomic_DNA.
DR   EMBL; AL390029; CAH70261.1; JOINED; Genomic_DNA.
DR   EMBL; AL160392; CAH70262.1; -; Genomic_DNA.
DR   EMBL; AL157694; CAH70262.1; JOINED; Genomic_DNA.
DR   EMBL; AL157760; CAH70262.1; JOINED; Genomic_DNA.
DR   EMBL; AL390029; CAH70262.1; JOINED; Genomic_DNA.
DR   EMBL; AL157694; CAH70656.1; -; Genomic_DNA.
DR   EMBL; AL157760; CAH70656.1; JOINED; Genomic_DNA.
DR   EMBL; AL160392; CAH70656.1; JOINED; Genomic_DNA.
DR   EMBL; AL390029; CAH70656.1; JOINED; Genomic_DNA.
DR   EMBL; AL157694; CAH70657.1; -; Genomic_DNA.
DR   EMBL; AL157760; CAH70657.1; JOINED; Genomic_DNA.
DR   EMBL; AL160392; CAH70657.1; JOINED; Genomic_DNA.
DR   EMBL; AL390029; CAH70657.1; JOINED; Genomic_DNA.
DR   EMBL; AL390029; CAI15720.1; -; Genomic_DNA.
DR   EMBL; AL157694; CAI15720.1; JOINED; Genomic_DNA.
DR   EMBL; AL157760; CAI15720.1; JOINED; Genomic_DNA.
DR   EMBL; AL160392; CAI15720.1; JOINED; Genomic_DNA.
DR   EMBL; AL390029; CAI15721.1; -; Genomic_DNA.
DR   EMBL; AL157694; CAI15721.1; JOINED; Genomic_DNA.
DR   EMBL; AL157760; CAI15721.1; JOINED; Genomic_DNA.
DR   EMBL; AL160392; CAI15721.1; JOINED; Genomic_DNA.
DR   EMBL; CH471075; EAX08550.1; -; Genomic_DNA.
DR   EMBL; CH471075; EAX08551.1; -; Genomic_DNA.
DR   EMBL; BC152456; AAI52457.1; -; mRNA.
DR   CCDS; CCDS55895.1; -. [O15075-4]
DR   CCDS; CCDS73561.1; -. [O15075-3]
DR   CCDS; CCDS81762.1; -. [O15075-1]
DR   CCDS; CCDS9354.1; -. [O15075-2]
DR   RefSeq; NP_001182344.1; NM_001195415.1. [O15075-3]
DR   RefSeq; NP_001182345.1; NM_001195416.1. [O15075-4]
DR   RefSeq; NP_001317000.1; NM_001330071.1. [O15075-1]
DR   RefSeq; NP_001317001.1; NM_001330072.1. [O15075-1]
DR   RefSeq; NP_004725.1; NM_004734.4. [O15075-2]
DR   UniGene; Hs.507755; -.
DR   UniGene; Hs.728619; -.
DR   PDB; 1MFW; X-ray; 1.60 A; A=49-154.
DR   PDB; 1MG4; X-ray; 1.50 A; A=49-154.
DR   PDB; 1UF0; NMR; -; A=54-156.
DR   PDB; 5JZJ; X-ray; 1.71 A; A/B=372-649.
DR   PDB; 5JZN; X-ray; 2.85 A; A/B=372-649.
DR   PDBsum; 1MFW; -.
DR   PDBsum; 1MG4; -.
DR   PDBsum; 1UF0; -.
DR   PDBsum; 5JZJ; -.
DR   PDBsum; 5JZN; -.
DR   ProteinModelPortal; O15075; -.
DR   SMR; O15075; -.
DR   BioGrid; 114635; 14.
DR   IntAct; O15075; 8.
DR   STRING; 9606.ENSP00000255448; -.
DR   BindingDB; O15075; -.
DR   ChEMBL; CHEMBL5683; -.
DR   GuidetoPHARMACOLOGY; 2005; -.
DR   iPTMnet; O15075; -.
DR   PhosphoSitePlus; O15075; -.
DR   SwissPalm; O15075; -.
DR   BioMuta; DCLK1; -.
DR   EPD; O15075; -.
DR   MaxQB; O15075; -.
DR   PaxDb; O15075; -.
DR   PeptideAtlas; O15075; -.
DR   PRIDE; O15075; -.
DR   DNASU; 9201; -.
DR   Ensembl; ENST00000255448; ENSP00000255448; ENSG00000133083. [O15075-2]
DR   Ensembl; ENST00000360631; ENSP00000353846; ENSG00000133083. [O15075-1]
DR   Ensembl; ENST00000379893; ENSP00000369223; ENSG00000133083. [O15075-4]
DR   Ensembl; ENST00000615680; ENSP00000484452; ENSG00000133083. [O15075-3]
DR   GeneID; 9201; -.
DR   KEGG; hsa:9201; -.
DR   UCSC; uc001uve.4; human. [O15075-1]
DR   CTD; 9201; -.
DR   DisGeNET; 9201; -.
DR   GeneCards; DCLK1; -.
DR   HGNC; HGNC:2700; DCLK1.
DR   HPA; CAB012405; -.
DR   HPA; HPA015040; -.
DR   HPA; HPA015655; -.
DR   MIM; 604742; gene.
DR   neXtProt; NX_O15075; -.
DR   OpenTargets; ENSG00000133083; -.
DR   PharmGKB; PA162383325; -.
DR   eggNOG; KOG0032; Eukaryota.
DR   eggNOG; KOG3757; Eukaryota.
DR   eggNOG; ENOG410YA63; LUCA.
DR   GeneTree; ENSGT00840000129744; -.
DR   HOGENOM; HOG000233016; -.
DR   HOVERGEN; HBG003790; -.
DR   InParanoid; O15075; -.
DR   KO; K08805; -.
DR   OMA; MVTCLQD; -.
DR   OrthoDB; EOG091G02RF; -.
DR   PhylomeDB; O15075; -.
DR   TreeFam; TF318770; -.
DR   BRENDA; 2.7.11.1; 2681.
DR   SignaLink; O15075; -.
DR   ChiTaRS; DCLK1; human.
DR   EvolutionaryTrace; O15075; -.
DR   GeneWiki; DCLK1; -.
DR   GenomeRNAi; 9201; -.
DR   PRO; PR:O15075; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   Bgee; ENSG00000133083; -.
DR   CleanEx; HS_DCLK1; -.
DR   ExpressionAtlas; O15075; baseline and differential.
DR   Genevisible; O15075; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005622; C:intracellular; IBA:GO_Central.
DR   GO; GO:0014069; C:postsynaptic density; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; TAS:ProtInc.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0005057; F:signal transducer activity, downstream of receptor; TAS:ProtInc.
DR   GO; GO:0048675; P:axon extension; IEA:Ensembl.
DR   GO; GO:0007417; P:central nervous system development; TAS:ProtInc.
DR   GO; GO:0021952; P:central nervous system projection neuron axonogenesis; IEA:Ensembl.
DR   GO; GO:0048813; P:dendrite morphogenesis; IEA:Ensembl.
DR   GO; GO:0016197; P:endosomal transport; NAS:UniProtKB.
DR   GO; GO:0030900; P:forebrain development; IEA:Ensembl.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:1900181; P:negative regulation of protein localization to nucleus; IEA:Ensembl.
DR   GO; GO:0007399; P:nervous system development; TAS:ProtInc.
DR   GO; GO:0001764; P:neuron migration; IEA:Ensembl.
DR   GO; GO:0048812; P:neuron projection morphogenesis; IBA:GO_Central.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
DR   GO; GO:0018107; P:peptidyl-threonine phosphorylation; IBA:GO_Central.
DR   GO; GO:0006468; P:protein phosphorylation; TAS:ProtInc.
DR   GO; GO:0009615; P:response to virus; IEP:UniProtKB.
DR   CDD; cd01617; DCX; 2.
DR   Gene3D; 3.10.20.230; -; 2.
DR   InterPro; IPR020636; Ca/CaM-dep_Ca-dep_prot_Kinase.
DR   InterPro; IPR003533; Doublecortin_dom.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR24347; PTHR24347; 1.
DR   Pfam; PF03607; DCX; 2.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00537; DCX; 2.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   SUPFAM; SSF89837; SSF89837; 2.
DR   PROSITE; PS50309; DC; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Developmental protein; Differentiation; Kinase; Neurogenesis;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   Repeat; Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    740       Serine/threonine-protein kinase DCLK1.
FT                                /FTId=PRO_0000085919.
FT   DOMAIN       57    143       Doublecortin 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00072}.
FT   DOMAIN      186    269       Doublecortin 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00072}.
FT   DOMAIN      390    647       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     396    404       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   COMPBIAS    288    340       Pro/Ser-rich.
FT   COMPBIAS    698    701       Poly-Arg.
FT   ACT_SITE    511    511       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     419    419       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES      32     32       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9JLM8}.
FT   MOD_RES      36     36       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9JLM8}.
FT   MOD_RES      46     46       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q9JLM8}.
FT   MOD_RES     305    305       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9JLM8}.
FT   MOD_RES     307    307       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9JLM8}.
FT   MOD_RES     330    330       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9JLM8}.
FT   MOD_RES     332    332       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9JLM8}.
FT   MOD_RES     334    334       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9JLM8}.
FT   MOD_RES     337    337       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9JLM8}.
FT   MOD_RES     347    347       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9JLM8}.
FT   MOD_RES     352    352       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     353    353       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O08875}.
FT   MOD_RES     355    355       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9JLM8}.
FT   MOD_RES     364    364       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9JLM8}.
FT   MOD_RES     376    376       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9JLM8}.
FT   MOD_RES     520    520       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q9JLM8}.
FT   MOD_RES     726    726       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9JLM8}.
FT   MOD_RES     735    735       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9JLM8}.
FT   MOD_RES     738    738       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9JLM8}.
FT   VAR_SEQ       1    307       Missing (in isoform 3 and isoform 4).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:9747029}.
FT                                /FTId=VSP_004905.
FT   VAR_SEQ     308    313       PASTSS -> MLELIE (in isoform 3 and
FT                                isoform 4). {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:9747029}.
FT                                /FTId=VSP_004906.
FT   VAR_SEQ     687    740       TTALDKERQVFRRRRNQDVRSRYKAQPAPPELNSESEDYSP
FT                                SSSETVRSPNSPF -> LDHGFTIKRSGSLDYYQQPGMYWI
FT                                RPPLLIRRGRFSDEDATRM (in isoform 1 and
FT                                isoform 3). {ECO:0000303|PubMed:10036192,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9205841,
FT                                ECO:0000303|PubMed:9747029}.
FT                                /FTId=VSP_004907.
FT   VARIANT      29     29       G -> C (in a gastric adenocarcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_045673.
FT   VARIANT      46     46       T -> M (in a gastric adenocarcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_045674.
FT   VARIANT      93     93       R -> Q (in a gastric adenocarcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_045675.
FT   VARIANT     291    291       S -> F (in a gastric adenocarcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_045676.
FT   VARIANT     292    292       R -> H (in dbSNP:rs56185003).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_045677.
FT   HELIX        53     55       {ECO:0000244|PDB:1MFW}.
FT   STRAND       56     63       {ECO:0000244|PDB:1MG4}.
FT   STRAND       72     76       {ECO:0000244|PDB:1MG4}.
FT   TURN         78     80       {ECO:0000244|PDB:1MG4}.
FT   HELIX        84     95       {ECO:0000244|PDB:1MG4}.
FT   STRAND       98    101       {ECO:0000244|PDB:1MG4}.
FT   STRAND      107    110       {ECO:0000244|PDB:1MG4}.
FT   HELIX       120    122       {ECO:0000244|PDB:1MG4}.
FT   STRAND      128    135       {ECO:0000244|PDB:1MG4}.
FT   TURN        142    145       {ECO:0000244|PDB:1MG4}.
FT   HELIX       148    151       {ECO:0000244|PDB:1MG4}.
FT   HELIX       384    389       {ECO:0000244|PDB:5JZJ}.
FT   STRAND      390    398       {ECO:0000244|PDB:5JZJ}.
FT   STRAND      400    409       {ECO:0000244|PDB:5JZJ}.
FT   TURN        410    412       {ECO:0000244|PDB:5JZJ}.
FT   STRAND      415    422       {ECO:0000244|PDB:5JZJ}.
FT   STRAND      427    429       {ECO:0000244|PDB:5JZJ}.
FT   HELIX       436    440       {ECO:0000244|PDB:5JZJ}.
FT   STRAND      451    456       {ECO:0000244|PDB:5JZJ}.
FT   STRAND      458    466       {ECO:0000244|PDB:5JZJ}.
FT   HELIX       473    480       {ECO:0000244|PDB:5JZJ}.
FT   HELIX       485    504       {ECO:0000244|PDB:5JZJ}.
FT   HELIX       514    516       {ECO:0000244|PDB:5JZJ}.
FT   STRAND      517    521       {ECO:0000244|PDB:5JZJ}.
FT   STRAND      527    531       {ECO:0000244|PDB:5JZJ}.
FT   TURN        551    553       {ECO:0000244|PDB:5JZJ}.
FT   HELIX       556    560       {ECO:0000244|PDB:5JZJ}.
FT   HELIX       568    582       {ECO:0000244|PDB:5JZJ}.
FT   HELIX       596    603       {ECO:0000244|PDB:5JZJ}.
FT   TURN        610    615       {ECO:0000244|PDB:5JZJ}.
FT   HELIX       618    627       {ECO:0000244|PDB:5JZJ}.
FT   TURN        632    634       {ECO:0000244|PDB:5JZJ}.
FT   HELIX       638    643       {ECO:0000244|PDB:5JZJ}.
FT   HELIX       645    647       {ECO:0000244|PDB:5JZJ}.
SQ   SEQUENCE   740 AA;  82224 MW;  D7B6D855099A315C CRC64;
     MSFGRDMELE HFDERDKAQR YSRGSRVNGL PSPTHSAHCS FYRTRTLQTL SSEKKAKKVR
     FYRNGDRYFK GIVYAISPDR FRSFEALLAD LTRTLSDNVN LPQGVRTIYT IDGLKKISSL
     DQLVEGESYV CGSIEPFKKL EYTKNVNPNW SVNVKTTSAS RAVSSLATAK GSPSEVRENK
     DFIRPKLVTI IRSGVKPRKA VRILLNKKTA HSFEQVLTDI TDAIKLDSGV VKRLYTLDGK
     QVMCLQDFFG DDDIFIACGP EKFRYQDDFL LDESECRVVK STSYTKIASS SRRSTTKSPG
     PSRRSKSPAS TSSVNGTPGS QLSTPRSGKS PSPSPTSPGS LRKQRSSQHG GSSTSLASTK
     VCSSMDENDG PGEEVSEEGF QIPATITERY KVGRTIGDGN FAVVKECVER STAREYALKI
     IKKSKCRGKE HMIQNEVSIL RRVKHPNIVL LIEEMDVPTE LYLVMELVKG GDLFDAITST
     NKYTERDASG MLYNLASAIK YLHSLNIVHR DIKPENLLVY EHQDGSKSLK LGDFGLATIV
     DGPLYTVCGT PTYVAPEIIA ETGYGLKVDI WAAGVITYIL LCGFPPFRGS GDDQEVLFDQ
     ILMGQVDFPS PYWDNVSDSA KELITMMLLV DVDQRFSAVQ VLEHPWVNDD GLPENEHQLS
     VAGKIKKHFN TGPKPNSTAA GVSVIATTAL DKERQVFRRR RNQDVRSRYK AQPAPPELNS
     ESEDYSPSSS ETVRSPNSPF
//
